Descriptions

ETV1 is a member of the ETS transcription factors, often overexpressed in prostate cancer. ETV1 has regions N- and C-terminal to the ETS domain that cooperate to inhibit DNA binding, involving structured and disordered regions. The C-terminal inhibitory domain (CID) includes an α-helix that perturbs the DNA-recognition helix, while the N-terminal inhibitory domain (NID) is intrinsically disordered and mediates autoinhibition through transient interactions. The activity of ETV1 can be alleviated by acetylation of lysine residues within NID.

Autoinhibitory domains (AIDs)

Target domain

334-419 (ETS domain)

Relief mechanism

PTM

Assay

Structural analysis, Deletion assay, Mutagenesis experiment, Split protein assay

Target domain

334-419 (ETS domain)

Relief mechanism

PTM

Assay

Structural analysis, Deletion assay, Mutagenesis experiment, Split protein assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for P50549

Entry ID Method Resolution Chain Position Source
4AVP X-ray 182 A A/B/C/D 326-429 PDB
4BNC X-ray 290 A A 326-429 PDB
5ILS X-ray 140 A A 334-434 PDB
AF-P50549-F1 Predicted AlphaFoldDB

387 variants for P50549

Variant ID(s) Position Change Description Diseaes Association Provenance
CA4167300
rs777428309
4 F>S No ClinGen
ExAC
gnomAD
rs777428309
CA366872172
4 F>Y No ClinGen
ExAC
gnomAD
CA366872095
rs1218883502
8 Q>R No ClinGen
gnomAD
rs1351415009
CA366872081
9 V>A No ClinGen
gnomAD
rs753008700
CA4167298
12 M>R No ClinGen
ExAC
gnomAD
rs757988982
CA4167299
12 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1376879279
CA366872030
13 V>F No ClinGen
gnomAD
CA366871996
rs373945413
15 N>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 15 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA366871131
rs1453046202
16 S>G No ClinGen
gnomAD
CA4167236
rs555395802
18 R>C No ClinGen
1000Genomes
ExAC
gnomAD
rs1338879591
CA366871071
18 R>H No ClinGen
gnomAD
rs776051542
CA4167234
19 G>A No ClinGen
ExAC
gnomAD
CA4167235
rs535092479
19 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4167233
rs770257114
20 R>T No ClinGen
ExAC
CA154005984
rs367998229
24 E>Q No ClinGen
ESP
rs781735914
CA4167231
25 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA4167229
rs747119926
26 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs747119926
CA4167230
26 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs777711910
CA4167228
28 N>S No ClinGen
ExAC
gnomAD
rs752895151
CA4167226
29 V>D No ClinGen
ExAC
gnomAD
CA4167223
rs750167942
32 R>G No ClinGen
ExAC
gnomAD
rs374496805
CA4167222
37 R>S No ClinGen
ESP
ExAC
CA4167221
rs761586548
38 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs972620421
CA154005924
38 D>N No ClinGen
TOPMed
gnomAD
TCGA novel 38 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1397294224
CA366870629
40 A>G No ClinGen
TOPMed
CA154005904
rs939052748
40 A>S No ClinGen
TOPMed
rs1334696169
CA366870615
41 H>Q No ClinGen
TOPMed
rs771177778
CA4167193
45 E>V No ClinGen
ExAC
gnomAD
rs773621570
CA4167191
49 D>V No ClinGen
ExAC
gnomAD
TCGA novel 50 L>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772517181
CA4167190
52 Q>H No ClinGen
ExAC
gnomAD
CA154004883
rs945739812
52 Q>R No ClinGen
Ensembl
rs748240043
CA4167189
56 T>K No ClinGen
ExAC
gnomAD
CA366870286
rs1265128802
57 W>* No ClinGen
gnomAD
rs768930207
CA4167187
57 W>G No ClinGen
ExAC
gnomAD
rs1209187179
CA366870275
58 L>F No ClinGen
gnomAD
CA4167141
rs376325638
62 Q>E No ClinGen
ExAC
gnomAD
rs1283182375
CA366865826
64 P>H No ClinGen
gnomAD
CA366865830
rs1377461633
64 P>T No ClinGen
gnomAD
rs1295869839
CA366865803
65 D>E No ClinGen
gnomAD
CA366865817
rs1341827936
65 D>N No ClinGen
gnomAD
CA366865757
rs1399298408
68 E>K No ClinGen
gnomAD
CA366865730
rs1193052352
69 Q>* No ClinGen
TOPMed
CA366865693
rs1403337828
71 V>L No ClinGen
gnomAD
rs1412813233
CA366865663
73 D>H No ClinGen
gnomAD
CA4167139
rs768811949
74 Y>* No ClinGen
ExAC
gnomAD
rs985561471
CA153998256
74 Y>N No ClinGen
TOPMed
rs1435454184
CA366865579
77 E>K No ClinGen
TOPMed
CA366873912
rs1487823864
79 L>F No ClinGen
gnomAD
CA366873903
rs1247959899
80 A>G No ClinGen
TOPMed
CA366873907
rs1246463552
80 A>S No ClinGen
gnomAD
CA366873901
rs1247959899
80 A>V No ClinGen
TOPMed
CA366873887
rs1288719773
81 F>L No ClinGen
TOPMed
gnomAD
CA4167120
rs749235215
81 F>L No ClinGen
ExAC
gnomAD
rs1583710223
CA366873874
83 G>A No ClinGen
Ensembl
CA366873864
rs1217388375
85 P>Q No ClinGen
TOPMed
gnomAD
rs1302857335
CA366873865
85 P>S No ClinGen
gnomAD
rs1280099827
CA366873837
89 K>R No ClinGen
gnomAD
CA4167114
rs769910514
96 C>F No ClinGen
ExAC
TOPMed
gnomAD
CA4167113
rs371614424
97 S>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1359804481
CA366873777
98 E>K No ClinGen
gnomAD
CA4167112
rs758881224
99 I>V No ClinGen
ExAC
gnomAD
CA4167110
rs9639168
100 S>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4167109
rs9639168
VAR_048948
100 S>G No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA366873758
rs1442372291
100 S>R No ClinGen
TOPMed
rs1562649064
CA366873734
104 S>T No ClinGen
Ensembl
rs753912647
CA4167108
105 Q>E No ClinGen
ExAC
gnomAD
CA366873724
rs1197619453
105 Q>H No ClinGen
gnomAD
rs1257214692
CA366873719
106 E>G No ClinGen
gnomAD
rs936225135
CA154019187
106 E>Q No ClinGen
TOPMed
gnomAD
rs1583709631
CA366873711
107 Q>R No ClinGen
Ensembl
rs1374621781
CA366873702
108 P>H No ClinGen
TOPMed
CA154019175
rs943501720
109 F>L No ClinGen
Ensembl
rs1284796770
CA366873700
109 F>L No ClinGen
gnomAD
rs774071237
CA4167105
111 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1308339889
CA366873678
112 S>G No ClinGen
gnomAD
CA366873676
rs1446300469
112 S>T No ClinGen
gnomAD
COSM1134279
COSM452453
rs762835509
CA4167103
114 G>A Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA4167104
rs768475054
114 G>R No ClinGen
ExAC
gnomAD
COSM3942071
CA4167102
rs775525239
COSM3942070
116 K>N oesophagus [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs1131845
CA366873640
117 C>F No ClinGen
ExAC
gnomAD
rs1131845
CA4167101
117 C>Y No ClinGen
ExAC
gnomAD
rs780679319
CA4167099
118 L>V No ClinGen
ExAC
gnomAD
rs1424792522
CA366873629
119 Y>* No ClinGen
gnomAD
CA4167098
rs368739038
119 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1288074041
CA366873632
119 Y>H No ClinGen
TOPMed
rs368739038
CA154019134
119 Y>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4167097
rs746647484
120 N>S No ClinGen
ExAC
gnomAD
rs779138336
CA4167076
123 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs755598582
CA4167075
124 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA154015755
rs1035510272
125 D>G No ClinGen
TOPMed
rs780320230
CA4167073
125 D>N No ClinGen
ExAC
gnomAD
rs1405710659
CA366873068
127 K>R No ClinGen
gnomAD
rs867637434
CA154015733
130 V>M No ClinGen
Ensembl
CA154015725
rs1003578447
131 G>E No ClinGen
TOPMed
rs1292201648
CA366873029
133 R>T No ClinGen
gnomAD
CA4167070
rs767789988
134 P>A No ClinGen
ExAC
gnomAD
CA366872987
rs1488719060
136 N>K No ClinGen
gnomAD
CA4167069
rs757351742
136 N>S No ClinGen
ExAC
gnomAD
CA366873004
rs757351742
136 N>T No ClinGen
ExAC
gnomAD
CA4167067
rs779956322
137 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs779956322
CA4167068
137 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs776585267
CA4167065
138 P>H No ClinGen
ExAC
gnomAD
CA366872951
rs776585267
138 P>R No ClinGen
ExAC
gnomAD
rs769886672 139 T>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs771826241
CA4167060
139 T>K No ClinGen
ExAC
TOPMed
rs80157564
CA4167058
143 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA366872868
rs1489078903
144 P>L No ClinGen
gnomAD
TCGA novel 144 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769109922
CA4167056
145 V>A No ClinGen
ExAC
gnomAD
rs1356892841
CA366872866
145 V>L No ClinGen
TOPMed
rs1356892841
CA366872867
145 V>M No ClinGen
TOPMed
CA154015643
rs531167169
148 L>M No ClinGen
1000Genomes
CA4167055
rs749626646
149 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA366872797
rs1234581450
150 H>N No ClinGen
gnomAD
rs1562643963
CA366872762
151 A>E No ClinGen
Ensembl
rs370603971
CA4167053
154 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4167052
rs745962107
156 T>S No ClinGen
ExAC
gnomAD
CA366872693
rs1401494582
159 P>L Variant assessed as Somatic; 4.641e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs751704054
CA4167049
160 K>E No ClinGen
ExAC
gnomAD
CA4167048
rs764264160
161 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs1398904507
CA366872683
161 P>S No ClinGen
gnomAD
rs1398904507
CA366872685
161 P>T No ClinGen
gnomAD
rs186330943
CA4167046
163 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs376556632
CA4167047
163 R>W No ClinGen
ESP
ExAC
gnomAD
rs766310266
CA4167045
164 A>D No ClinGen
ExAC
gnomAD
rs1257458642
CA366872668
164 A>T No ClinGen
TOPMed
CA4167043
rs772835188
167 A>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 167 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760526649
CA4167044
167 A>T No ClinGen
ExAC
TOPMed
rs1583696319
CA366872611
168 H>P No ClinGen
Ensembl
CA154015563
rs1035537936
169 L>F No ClinGen
Ensembl
rs1583696273
CA366872581
170 P>T No ClinGen
Ensembl
rs761565850
CA4167041
172 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA366872524
rs1220309725
173 Q>H No ClinGen
gnomAD
CA366872492
rs1201072184
175 I>T No ClinGen
gnomAD
CA366872501
rs1367391521
175 I>V No ClinGen
gnomAD
CA4167039
rs370813002
176 P>R No ClinGen
1000Genomes
ESP
ExAC
gnomAD
CA154015527
rs1040534574
176 P>S No ClinGen
TOPMed
gnomAD
CA366872460
rs1311705778
177 D>V No ClinGen
TOPMed
rs770397289
CA4167036
180 Y>H No ClinGen
ExAC
gnomAD
CA4167035
rs373406059
182 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1334842844
CA366872356
183 D>Y No ClinGen
TOPMed
gnomAD
TCGA novel 184 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4167012
COSM1596792
rs748346103
COSM260728
187 R>C Variant assessed as Somatic; 0.0 impact. large_intestine endometrium breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4167011
COSM181336
rs779937870
187 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs755892534
CA4167010
188 R>C No ClinGen
ExAC
gnomAD
CA366871330
rs755892534
188 R>G No ClinGen
ExAC
gnomAD
CA154011751
rs568607536
188 R>H No ClinGen
1000Genomes
TOPMed
rs568607536
CA366871328
188 R>L No ClinGen
1000Genomes
TOPMed
TCGA novel 189 Q>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1229655088
CA366871319
190 L>I No ClinGen
gnomAD
rs1229655088
CA366871318
190 L>V No ClinGen
gnomAD
CA366871300
rs1178112843
192 E>D No ClinGen
TOPMed
CA366871295
rs1312149572
193 P>R No ClinGen
TOPMed
gnomAD
COSM3942068
CA366871274
rs1301021932
COSM3942069
196 S>C oesophagus [Cosmic] No ClinGen
cosmic curated
TOPMed
rs781001175
CA4167008
198 P>L No ClinGen
ExAC
gnomAD
rs750183378
CA4167009
198 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1296192613
CA366871244
199 P>H No ClinGen
gnomAD
rs1296192613
CA366871242
199 P>R No ClinGen
gnomAD
CA4167006
rs751178726
201 P>L No ClinGen
ExAC
TOPMed
gnomAD
COSM1086183
COSM1596793
rs752431857
CA4167003
202 T>M Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4167001
rs759831524
203 M>T No ClinGen
ExAC
gnomAD
CA4167000
rs776991837
204 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs758115478
CA154011705
204 P>R No ClinGen
Ensembl
CA366871185
rs776991837
204 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA366871154
rs1425958431
206 E>V No ClinGen
gnomAD
rs771410991
CA4166999
208 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs771410991
CA366871119
208 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA154011697
COSM1448524
COSM1448523
rs959752124
208 R>H large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
TCGA novel 209 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs928308446
CA154011695
209 P>T No ClinGen
Ensembl
CA366871073
rs1187578622
210 M>R No ClinGen
TOPMed
CA4166998
rs368628777
210 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4166997
rs563398201
211 Y>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs772105404
COSM280879
CA4166996
213 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA4166995
rs748182764
213 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs772105404
CA366871018
213 R>S No ClinGen
ExAC
gnomAD
rs1413426753
CA366870899
217 E>D No ClinGen
TOPMed
rs1213895329
CA366870881
218 P>L No ClinGen
TOPMed
gnomAD
rs1213895329
CA366870883
218 P>R No ClinGen
TOPMed
gnomAD
rs971724465
CA154011670
218 P>S No ClinGen
TOPMed
CA4166992
rs745655098
219 N>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 219 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1276574918
CA366870850
220 I>F No ClinGen
gnomAD
rs1159395009
CA366870821
221 P>L No ClinGen
Ensembl
CA4166991
rs781034658
221 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA4166989
rs746914419
224 P>L No ClinGen
ExAC
gnomAD
CA366870692
rs1303518990
229 Q>E No ClinGen
TOPMed
gnomAD
CA366870676
rs1168478482
230 E>* No ClinGen
gnomAD
rs370376322
CA154011619
230 E>D No ClinGen
ESP
rs577222571
CA154011615
232 H>Q No ClinGen
TOPMed
gnomAD
CA4166987
rs758005694
233 D>N No ClinGen
ExAC
gnomAD
rs752193835
CA4166986
234 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA154011589
rs752193835
234 P>T No ClinGen
ExAC
TOPMed
gnomAD
CA4166985
rs764806499
236 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs1252832989
CA366870601
236 Y>N No ClinGen
gnomAD
CA4166984
rs754658233
237 E>D No ClinGen
ExAC
gnomAD
rs1405263724
CA366870572
238 H>D No ClinGen
gnomAD
rs766745552
CA4166982
238 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA4166983
rs754217454
238 H>R No ClinGen
ExAC
gnomAD
rs761207813
CA4166981
239 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA4166980
rs773736818
239 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs767959199
CA4166979
240 T>A No ClinGen
ExAC
gnomAD
rs749510540
CA4166975
241 M>I No ClinGen
ExAC
rs768827110
CA4166977
241 M>K No ClinGen
ExAC
TOPMed
gnomAD
rs768827110
CA4166976
241 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA154011558
rs1028802115
241 M>V No ClinGen
TOPMed
gnomAD
rs776337760
CA4166974
242 V>D No ClinGen
ExAC
gnomAD
rs977319524
CA154011538
243 G>C No ClinGen
TOPMed
gnomAD
rs1296693133
CA366870531
243 G>V No ClinGen
gnomAD
rs180893787
CA366870526
244 S>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs180893787
CA4166973
244 S>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4166972
rs777866452
245 A>E No ClinGen
ExAC
gnomAD
CA4166971
COSM1596794
rs777866452
COSM1086182
245 A>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1241848276
CA366870515
246 A>G No ClinGen
gnomAD
CA4166968
rs778475905
247 S>G No ClinGen
ExAC
TOPMed
gnomAD
rs1159668213
CA366870509
247 S>N No ClinGen
gnomAD
rs759316974
CA4166967
247 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs756490851
CA4166965
CA4166964
249 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA4166966
rs753499919
249 S>T No ClinGen
ExAC
gnomAD
CA4166963
rs750724962
250 F>I No ClinGen
ExAC
gnomAD
TCGA novel 251 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA154011488
rs904139873
251 P>S No ClinGen
Ensembl
CA366870478
rs1251079501
252 P>L No ClinGen
gnomAD
CA4166962
rs768012173
252 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs1208611662
CA366870476
253 P>A No ClinGen
gnomAD
rs1291952347
CA366870461
255 M>L No ClinGen
TOPMed
CA366870455
rs1375655486
255 M>R No ClinGen
TOPMed
CA4166959
rs774351239
258 Q>E No ClinGen
ExAC
gnomAD
CA4166957
rs762903267
260 P>S No ClinGen
ExAC
gnomAD
rs1562636289
CA366870336
263 F>L No ClinGen
Ensembl
CA366870343
rs1379964139
263 F>S No ClinGen
gnomAD
rs770085059
CA4166955
264 A>T No ClinGen
ExAC
gnomAD
CA4166954
rs746805857
265 Y>H No ClinGen
ExAC
TOPMed
gnomAD
rs1248799839
CA366870293
266 D>G No ClinGen
TOPMed
CA4166952
rs541367225
267 S>A No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 268 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs987675030
CA153992819
269 V>M No ClinGen
Ensembl
CA4166916
rs766460224
271 S>R No ClinGen
ExAC
gnomAD
rs1583596404
CA366863959
271 S>T No ClinGen
Ensembl
rs1443548846
CA366863924
273 H>R No ClinGen
gnomAD
CA4166915
rs761678364
273 H>Y No ClinGen
ExAC
gnomAD
rs773946563
CA4166914
274 S>C No ClinGen
ExAC
gnomAD
CA366863890
rs1240725621
277 M>I No ClinGen
gnomAD
rs775029555
CA4166911
279 Q>H No ClinGen
ExAC
gnomAD
CA366863866
rs1562600592
280 E>D No ClinGen
Ensembl
rs769261497
CA366863861
281 G>A No ClinGen
ExAC
TOPMed
gnomAD
rs769261497
CA4166910
281 G>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 282 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776280186
CA4166909
283 L>P No ClinGen
ExAC
gnomAD
rs776280186
CA4166908
283 L>R No ClinGen
ExAC
gnomAD
rs1187405618
CA366863849
284 A>T No ClinGen
TOPMed
rs777988147
CA4166905
285 H>R No ClinGen
ExAC
gnomAD
rs747474762
CA4166906
285 H>Y No ClinGen
ExAC
gnomAD
rs1458591065
CA366863832
286 P>L No ClinGen
TOPMed
gnomAD
TCGA novel 286 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA366863830
rs1430368948
287 S>G No ClinGen
TOPMed
CA4166903
rs779524119
CA4166902
287 S>R No ClinGen
ExAC
gnomAD
rs372865361
CA4166904
287 S>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA153992733
rs369547662
289 T>A No ClinGen
ESP
TOPMed
gnomAD
rs892838838
CA153992723
289 T>I No ClinGen
TOPMed
gnomAD
rs369547662
CA153992731
289 T>P No ClinGen
ESP
TOPMed
gnomAD
CA366863814
rs1389115367
290 E>K No ClinGen
gnomAD
rs1477141221
CA366863299
292 C>S No ClinGen
TOPMed
rs756408088
CA4166881
293 M>V No ClinGen
ExAC
gnomAD
rs74772438
CA153991506
295 E>* No ClinGen
Ensembl
rs750579850
CA4166880
295 E>V No ClinGen
ExAC
TOPMed
gnomAD
CA366863209
rs1562598110
297 G>V No ClinGen
Ensembl
TCGA novel 297 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs758211416
CA4166878
302 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA153991488
rs896651598
305 T>N No ClinGen
TOPMed
rs765227604
CA366862974
312 F>L No ClinGen
ExAC
TOPMed
gnomAD
rs1349555738
COSM275010
CA366862968
313 D>N Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA366862955
rs1406293329
313 D>V No ClinGen
TOPMed
CA366862964
rs1349555738
313 D>Y No ClinGen
gnomAD
CA366861420
rs1224599336
315 D>H No ClinGen
gnomAD
rs775881552
CA4166847
318 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs536351715
CA4166845
320 P>S No ClinGen
1000Genomes
ExAC
gnomAD
CA366861283
rs1376539902
322 M>I No ClinGen
gnomAD
rs982098606
CA153988751
322 M>T No ClinGen
TOPMed
CA4166844
rs781237791
324 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA366861252
rs1433178930
324 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs971605664
CA153988729
326 G>E No ClinGen
TOPMed
gnomAD
CA4166843
rs771191756
326 G>R No ClinGen
ExAC
gnomAD
CA366861199
rs1299587625
327 P>L No ClinGen
TOPMed
gnomAD
rs1405125094
CA366861180
329 Y>N No ClinGen
gnomAD
CA366861134
rs1419836219
331 R>Q No ClinGen
TOPMed
gnomAD
CA366861142
rs1176085263
331 R>W No ClinGen
gnomAD
CA366861131
rs1259444979
332 R>Q Variant assessed as Somatic; 4.659e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA153988718
rs573599843
333 G>R No ClinGen
gnomAD
rs1485213898
CA366861108
336 Q>P No ClinGen
gnomAD
rs1216726802
CA366861088
339 Q>K No ClinGen
gnomAD
TCGA novel 341 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1237814069
CA366861065
342 V>I No ClinGen
TOPMed
CA4166841
rs777934934
343 A>D No ClinGen
ExAC
gnomAD
CA366861055
rs777934934
343 A>V No ClinGen
ExAC
gnomAD
rs1356187071
CA366861039
346 D>G No ClinGen
gnomAD
CA153988667
rs28565271
347 D>A No ClinGen
Ensembl
CA366861004
rs1413540602
348 P>L No ClinGen
gnomAD
CA4166839
rs753613347
348 P>S No ClinGen
ExAC
gnomAD
CA366860940
rs1375201232
352 H>L No ClinGen
gnomAD
rs567326719
CA4166837
355 A>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs567326719
CA4166838
355 A>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA366860878
rs1426366330
355 A>V No ClinGen
TOPMed
TCGA novel 356 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749957333
CA4166836
357 T>S No ClinGen
ExAC
gnomAD
rs767110553
CA4166835
358 G>C No ClinGen
ExAC
gnomAD
CA366860834
COSM1596797
rs1419462186
COSM1086160
359 R>* Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA366860832
rs1185683021
359 R>Q No ClinGen
gnomAD
rs757006753
CA4166834
361 M>I No ClinGen
ExAC
gnomAD
rs1262376457
CA366860799
362 E>Q No ClinGen
gnomAD
rs1157380856
CA366860738
365 L>P No ClinGen
gnomAD
CA366860728
rs1479276970
366 I>T No ClinGen
TOPMed
gnomAD
CA366860711
rs372949158
367 E>D No ClinGen
1000Genomes
ExAC
gnomAD
rs751054044
CA4166811
371 V>G No ClinGen
ExAC
gnomAD
CA4166810
rs763657436
372 A>G No ClinGen
ExAC
gnomAD
CA4166809
rs758057612
374 R>C No ClinGen
ExAC
gnomAD
CA4166808
rs753053339
374 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1272210222
CA366860154
377 I>F No ClinGen
TOPMed
rs1272210222
CA366860155
377 I>V No ClinGen
TOPMed
CA366860046
rs1274578649
391 R>H No ClinGen
gnomAD
CA366860042
rs1235404016
392 S>* No ClinGen
gnomAD
rs1007679355
CA153983459
394 R>C No ClinGen
TOPMed
gnomAD
rs773278653
CA4166802
394 R>H No ClinGen
ExAC
gnomAD
rs1562584261
CA366859999
398 E>D No ClinGen
Ensembl
CA366859986
rs1313425487
400 G>E No ClinGen
gnomAD
CA366859981
rs1373470302
401 I>F No ClinGen
gnomAD
CA4166798
rs373175151
402 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1477845764
CA366859963
403 Q>R No ClinGen
gnomAD
rs1412188275
CA366858283
414 F>S No ClinGen
gnomAD
rs1583541678
CA366858236
421 L>V No ClinGen
Ensembl
rs1378164598
CA366858204
425 A>D No ClinGen
TOPMed
CA4166771
rs778635083
427 P>T No ClinGen
ExAC
gnomAD
rs1477637846
CA366858184
428 D>E No ClinGen
TOPMed
CA4166770
rs754625693
428 D>Y No ClinGen
ExAC
gnomAD
CA4166769
rs369611703
429 N>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs780370745
CA4166768
430 Q>H No ClinGen
ExAC
gnomAD
CA4166767
rs756650303
431 R>H No ClinGen
ExAC
gnomAD
CA4166766
rs750968701
434 L>R No ClinGen
ExAC
gnomAD
rs1341179503
CA366858139
435 K>Q No ClinGen
gnomAD
CA153978636
rs912799058
438 M>T No ClinGen
Ensembl
rs761964463
CA4166764
438 M>V No ClinGen
ExAC
gnomAD
CA366858058
rs1426228965
439 E>G No ClinGen
gnomAD
CA4166763
rs751525538
440 R>C No ClinGen
ExAC
gnomAD
rs1326846768
CA366858043
440 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1323464032
CA366858009
442 I>S No ClinGen
gnomAD
rs1348279586
CA366858019
442 I>V No ClinGen
gnomAD
rs776609162
CA4166760
444 E>K No ClinGen
ExAC
gnomAD
rs946189887
CA16040342
450 L>V No ClinGen
TOPMed
rs1475197955
CA366857886
452 H>Q No ClinGen
TOPMed
gnomAD
CA4166757
rs773216548
454 D>E No ClinGen
ExAC
gnomAD
rs770880512
CA366857877
454 D>H No ClinGen
ExAC
gnomAD
CA4166759
rs770880512
454 D>N No ClinGen
ExAC
gnomAD
rs771840153
CA4166756
455 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA366857773
rs1233150264
458 A>S No ClinGen
TOPMed
rs1466736141
CA366857760
459 Y>D No ClinGen
gnomAD
rs980097190
CA153978552
460 M>I No ClinGen
TOPMed
CA153978561
rs575326937
460 M>K No ClinGen
1000Genomes
TOPMed
CA4166755
rs747764806
460 M>V No ClinGen
ExAC
gnomAD
CA153978545
rs778277062
461 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs763469375
CA4166752
461 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA4166753
rs778277062
461 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA153978527
rs980825182
463 G>E No ClinGen
TOPMed
gnomAD
CA366857613
rs748904227
463 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA4166749
rs748904227
463 G>W No ClinGen
ExAC
TOPMed
gnomAD
CA4166748
rs779639875
464 G>V No ClinGen
ExAC
gnomAD
rs746160068
CA4166746
466 C>R No ClinGen
ExAC
TOPMed
gnomAD
rs781723736
CA4166745
466 C>Y No ClinGen
ExAC
gnomAD
rs1202950122
CA366857502
468 P>L No ClinGen
gnomAD
CA4166743
rs370168921
469 H>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA153978436
rs560856535
469 H>R No ClinGen
gnomAD
TCGA novel 469 H>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs370168921
CA4166742
469 H>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1175100756
COSM3721680
CA366857431
COSM3721679
472 N>S upper_aerodigestive_tract Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
COSM222117
rs536563766
CA4166740
473 E>K Variant assessed as Somatic; 0.0 impact. skin [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA366857383
rs1177230962
474 G>C No ClinGen
gnomAD
CA366857394
rs1177230962
474 G>S No ClinGen
gnomAD
rs567417512
CA4166738
COSM3381824
COSM3381823
475 Y>C pancreas [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
gnomAD
CA4166739
rs765499460
475 Y>H No ClinGen
ExAC
gnomAD
rs1404339912
CA366857298
476 V>G No ClinGen
TOPMed
rs767552829
CA4166736
476 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs767552829
COSM1251539
COSM1251540
CA16040343
476 V>M ovary oesophagus Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA366857266
rs1213250048
477 Y>* No ClinGen
TOPMed
gnomAD
rs746999865
CA153978369
477 Y>C No ClinGen
Ensembl

1 associated diseases with P50549

[MIM: 612219]: Ewing sarcoma (ES)

A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. . Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving ETV1 is found in patients with Ewing sarcoma. Translocation t(7;22)(p22;q12) with EWSR1. .

Without disease ID
  • A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. . Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving ETV1 is found in patients with Ewing sarcoma. Translocation t(7;22)(p22;q12) with EWSR1. .

9 regional properties for P50549

Type Name Position InterPro Accession
domain Protein kinase domain 288 - 539 IPR000719
domain SH2 domain 171 - 263 IPR000980
domain Serine-threonine/tyrosine-protein kinase, catalytic domain 288 - 538 IPR001245
domain SH3 domain 107 - 167 IPR001452
active_site Tyrosine-protein kinase, active site 405 - 417 IPR008266
domain F-actin binding 1061 - 1182 IPR015015
binding_site Protein kinase, ATP binding site 294 - 317 IPR017441
domain Tyrosine-protein kinase, catalytic domain 288 - 539 IPR020635
domain Tyrosine-protein kinase ABL, SH2 domain 169 - 262 IPR035837

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

5 GO annotations of molecular function

Name Definition
DNA-binding transcription activator activity, RNA polymerase II-specific A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription factor activity A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
sequence-specific double-stranded DNA binding Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding.

7 GO annotations of biological process

Name Definition
axon guidance The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
mechanosensory behavior Behavior that is dependent upon the sensation of a mechanical stimulus.
muscle organ development The process whose specific outcome is the progression of the muscle over time, from its formation to the mature structure. The muscle is an organ consisting of a tissue made up of various elongated cells that are specialized to contract and thus to produce movement and mechanical work.
peripheral nervous system neuron development The process whose specific outcome is the progression of a neuron whose cell body is located in the peripheral nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).

40 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A1A4L6 ETS2 Protein C-ets-2 Bos taurus (Bovine) SS
Q2KIC2 ETV1 ETS translocation variant 1 Bos taurus (Bovine) SS
P15062 ETS1 Transforming protein p68/c-ets-1 Gallus gallus (Chicken) SS
P10157 ETS2 Protein C-ets-2 Gallus gallus (Chicken) SS
Q90837 ERG Transcriptional regulator Erg Gallus gallus (Chicken) SS
A2T762 ETV3 ETS translocation variant 3 Pan troglodytes (Chimpanzee) PR
Q04688 Ets97D DNA-binding protein Ets97D Drosophila melanogaster (Fruit fly) PR
Q9Y603 ETV7 Transcription factor ETV7 Homo sapiens (Human) SS
P41212 ETV6 Transcription factor ETV6 Homo sapiens (Human) SS
P78545 ELF3 ETS-related transcription factor Elf-3 Homo sapiens (Human) SS
Q9UKW6 ELF5 ETS-related transcription factor Elf-5 Homo sapiens (Human) EV
P32519 ELF1 ETS-related transcription factor Elf-1 Homo sapiens (Human) PR
Q99607 ELF4 ETS-related transcription factor Elf-4 Homo sapiens (Human) PR
Q06546 GABPA GA-binding protein alpha chain Homo sapiens (Human) SS
O95238 SPDEF SAM pointed domain-containing Ets transcription factor Homo sapiens (Human) PR
P50548 ERF ETS domain-containing transcription factor ERF Homo sapiens (Human) PR
P41162 ETV3 ETS translocation variant 3 Homo sapiens (Human) PR
P11308 ERG Transcriptional regulator ERG Homo sapiens (Human) EV
P43268 ETV4 ETS translocation variant 4 Homo sapiens (Human) EV
P41161 ETV5 ETS translocation variant 5 Homo sapiens (Human) SS
P41970 ELK3 ETS domain-containing protein Elk-3 Homo sapiens (Human) SS
P28324 ELK4 ETS domain-containing protein Elk-4 Homo sapiens (Human) EV
P19419 ELK1 ETS domain-containing protein Elk-1 Homo sapiens (Human) EV
P15036 ETS2 Protein C-ets-2 Homo sapiens (Human) EV
P14921 ETS1 Protein C-ets-1 Homo sapiens (Human) EV
P41971 Elk3 ETS domain-containing protein Elk-3 Mus musculus (Mouse) EV
Q00422 Gabpa GA-binding protein alpha chain Mus musculus (Mouse) EV
P41969 Elk1 ETS domain-containing protein Elk-1 Mus musculus (Mouse) PR
P28322 Etv4 ETS translocation variant 4 Mus musculus (Mouse) SS
P15037 Ets2 Protein C-ets-2 Mus musculus (Mouse) SS
P27577 Ets1 Protein C-ets-1 Mus musculus (Mouse) EV
P70459 Erf ETS domain-containing transcription factor ERF Mus musculus (Mouse) PR
Q9CXC9 Etv5 ETS translocation variant 5 Mus musculus (Mouse) SS
P41158 Elk4 ETS domain-containing protein Elk-4 Mus musculus (Mouse) PR
P81270 Erg Transcriptional regulator ERG Mus musculus (Mouse) SS
P41164 Etv1 ETS translocation variant 1 Mus musculus (Mouse) SS
P41156 Ets1 Protein C-ets-1 Rattus norvegicus (Rat) SS
A4GTP4 Elk1 ETS domain-containing protein Elk-1 Rattus norvegicus (Rat) PR
Q9PUQ1 etv4 ETS translocation variant 4 Danio rerio (Zebrafish) (Brachydanio rerio) SS
A3FEM2 fev Protein FEV Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MDGFYDQQVP YMVTNSQRGR NCNEKPTNVR KRKFINRDLA HDSEELFQDL SQLQETWLAE
70 80 90 100 110 120
AQVPDNDEQF VPDYQAESLA FHGLPLKIKK EPHSPCSEIS SACSQEQPFK FSYGEKCLYN
130 140 150 160 170 180
VSAYDQKPQV GMRPSNPPTP SSTPVSPLHH ASPNSTHTPK PDRAFPAHLP PSQSIPDSSY
190 200 210 220 230 240
PMDHRFRRQL SEPCNSFPPL PTMPREGRPM YQRQMSEPNI PFPPQGFKQE YHDPVYEHNT
250 260 270 280 290 300
MVGSAASQSF PPPLMIKQEP RDFAYDSEVP SCHSIYMRQE GFLAHPSRTE GCMFEKGPRQ
310 320 330 340 350 360
FYDDTCVVPE KFDGDIKQEP GMYREGPTYQ RRGSLQLWQF LVALLDDPSN SHFIAWTGRG
370 380 390 400 410 420
MEFKLIEPEE VARRWGIQKN RPAMNYDKLS RSLRYYYEKG IMQKVAGERY VYKFVCDPEA
430 440 450 460 470
LFSMAFPDNQ RPLLKTDMER HINEEDTVPL SHFDESMAYM PEGGCCNPHP YNEGYVY